{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-078337","form_type":"8-K","ticker":"OTLK","cik":"0001649989","company_name":"Outlook Therapeutics, Inc.","filed_at":"2026-06-26T21:30:25+00:00","discovered_at":"2026-06-26T21:32:00.245846+00:00","generated_at":"2026-06-26T21:32:11.019310+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Outlook Therapeutics regains Nasdaq minimum bid price compliance, delisting risk removed","bullets":["Received Nasdaq letter on June 26, 2026 confirming compliance with bid price rule 5550(a)(2).","Closing bid price was $1.00 or greater for ten consecutive business days from June 11-25, 2026.","Prior delisting notice from February 18, 2026 for failing minimum bid price is now closed.","Common stock (OTLK) remains listed on Nasdaq Capital Market without further action needed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-078337","json":"https://secwatch.observer/filing/0001104659-26-078337.json","markdown":"https://secwatch.observer/filing/0001104659-26-078337.md","text":"https://secwatch.observer/filing/0001104659-26-078337.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926078337/0001104659-26-078337-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926078337/tm2619105d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T21:32:11.019310+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}